Lexicon Pharmaceuticals (LXRX) director receives new option and RSU grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Lexicon Pharmaceuticals director Raymond Debbane received new equity awards. On May 1, he was granted stock options for 43,478 shares of common stock at an exercise price of $1.61 per share, expiring in 2036.
The option vests in three equal annual installments on each of the first three anniversaries of the grant date. He also received 35,714 restricted stock units, which vest in full on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
DEBBANE RAYMOND
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 35,714 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 43,478 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 35,714 shares (Direct, null);
Stock Option (Right to Buy) — 43,478 shares (Direct, null)
Footnotes (1)
- Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of common stock. Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.
Key Figures
Option grant size: 43,478 shares
Option exercise price: $1.61 per share
Option expiration: May 1, 2036
+4 more
7 metrics
Option grant size
43,478 shares
Stock option grant on May 1, 2026
Option exercise price
$1.61 per share
Exercise price for granted stock options
Option expiration
May 1, 2036
Expiration date of stock options
RSU grant size
35,714 units
Restricted Stock Unit grant on May 1, 2026
RSU vesting
100% after 1 year
All RSUs vest on first anniversary of grant date
Post-grant option holdings
43,478 options
Total option-related derivative position after transaction
Post-grant RSU holdings
35,714 RSUs
Total RSU derivative position after transaction
Key Terms
Restricted Stock Units, stock options, exercise price, vesting, +1 more
5 terms
Restricted Stock Units financial
"The director received 35,714 restricted stock units, which vest in full on the first anniversary"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock options financial
"He was granted stock options for 43,478 shares of common stock at an exercise price of $1.61 per share"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"stock options for 43,478 shares of common stock at an exercise price of $1.61 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option vests in three equal annual installments on each of the first three anniversaries"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of common stock"
FAQ
What equity awards did Lexicon Pharmaceuticals (LXRX) director Raymond Debbane receive?
Raymond Debbane received stock options and restricted stock units as equity compensation. He was granted options on 43,478 shares at a $1.61 exercise price and 35,714 restricted stock units, each convertible into one share of common stock, subject to vesting conditions.
How do the new stock options for LXRX director Raymond Debbane vest?
The granted stock options vest over three years in equal portions. One third of the 43,478 option shares vest on each of the first three anniversaries of the May 1 grant date, aligning Debbane’s long-term incentives with Lexicon Pharmaceuticals’ performance over time.
What are the terms of the restricted stock units granted to the LXRX director?
The director received 35,714 restricted stock units that vest in a single tranche. All RSUs vest on the first anniversary of the May 1 grant date, and each unit represents a contingent right to receive one share of Lexicon Pharmaceuticals common stock upon vesting.
What is the exercise price and expiration date of the LXRX stock options granted?
The granted stock options have an exercise price of $1.61 per share, fixing the cost to acquire common stock. These options expire in 2036, providing a long-dated window for potential exercise after vesting, consistent with typical long-term director compensation structures.